Study of early stage non-small-cell lung cancer using Orbitrap-based global serum metabolomics

Journal of Cancer Research and Clinical Oncology

Volumn 143, Issue 4, 2017, Pages 649-659

  Klupczynska, Agnieszka ^a   Dereziński, Paweł ^a   Garrett, Timothy J ^b   Rubio, Vanessa Y ^b   Dyszkiewicz, Wojciech ^a   Kasprzyk, Mariusz ^a   Kokot, Zenon J ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Global metabolomics; Lung cancer; Mass spectrometry; Metabolite profiling; Orbitrap

Indexed keywords

HISTIDINE; LEUCINE; MALIC ACID; METHIONINE; PROPIONYLCARNITINE; PYROGLUTAMIC ACID;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER PATIENT; CANCER RESEARCH; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY CANCER; FEMALE; HUMAN; LUNG ADENOCARCINOMA; MALE; METABOLOMICS; NON SMALL CELL LUNG CANCER; PRECIPITATION; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; RECEIVER OPERATING CHARACTERISTIC; SQUAMOUS CELL LUNG CARCINOMA; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; BLOOD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LUNG TUMOR; MASS SPECTROMETRY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MASS SPECTROMETRY; METABOLOMICS;

EID: 85011663133     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-017-2347-0     Document Type: Article

References (43)

1. Aboud OA, Weiss RH (2013) New opportunities from the cancer metabolome. Clin Chem 59:138–146. doi:10.1373/clinchem.2012.184598
2. Balendiran GK, Dabur R, Fraser D (2004) The role of glutathione in cancer. Cell Biochem Funct 22:343–352
3. Brunelli L, Caiola E, Marabese M et al (2014) Capturing the metabolomic diversity of KRAS mutants in non-small-cell lung cancer cells. Oncotarget 5:4722–4731
4. Chambers MC, Maclean B, Burke R et al (2012) A cross-platform toolkit for mass spectrometry and proteomics. Nat Biotechnol 30:918–920. doi:10.1038/nbt.2377
5. Chen Y, Ma Z, Li A et al (2014) Metabolomic profiling of human serum in lung cancer patients using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry and gas chromatography/mass spectrometry. J Cancer Res Clin Oncol 141:705–718. doi:10.1007/s00432-014-1846-5
6. DeBerardinis RJ, Sayed N, Ditsworth D, Thompson CB (2008) Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev 18:54–61. doi:10.1016/j.gde.2008.02.003
7. Deja S, Porebska I, Kowal A, Zabek A, Barg W, Pawelczyk K, Stanimirova I, Daszykowski M, Korzeniewska A, Jankowska R, Mlynarz P (2014) Metabolomics provide new insights on lung cancer staging and discrimination from chronic obstructive pulmonary disease. J Pharm Biomed Anal 100:369–380. doi:10.1016/j.jpba.2014.08.020
8. Del Ferraro C, Grant M, Koczywas M, Dorr-Uyemura LA (2012) Management of anorexia-cachexia in late-stage lung cancer patients. J Hosp Palliat Nurs 14:397–404. doi:10.1097/NJH.0b013e31825f3470 (8p)
9. Estrela JM, Ortega a, Obrador E (2006) Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 43:143–181
10. Fahrmann JF, Kim K, Defelice BC et al (2015) Investigation of metabolomic blood biomarkers for detection of adenocarcinoma lung cancer. Cancer Epidemiol Prev Biomark 24:1716–1724. doi:10.1158/1055-9965.EPI-15-0427
11. Ganti S, Taylor SL, Kim K et al (2012) Urinary acylcarnitines are altered in human kidney cancer. Int J Cancer 130:2791–2800. doi:10.1002/ijc.26274
12. Geenen S, Guallar-Hoyas C, Michopoulos F et al (2011) HPLC-MS/MS methods for the quantitative analysis of 5-oxoproline (pyroglutamate) in rat plasma and hepatic cell line culture medium. J Pharm Biomed Anal 56:655–663. doi:10.1016/j.jpba.2011.06.001
13. Ghosh AK, Hirasawa N, Ohtsu H et al (2002) Defective angiogenesis in the inflammatory granulation tissue in histidine decarboxylase-deficient mice but not in mast cell-deficient mice. J Exp Med 195:973–982. doi:10.1084/jem.20011782
14. Goldstraw P, Crowley J, Chansky K et al (2007) The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2:706–714. doi:10.1097/JTO.0b013e31812f3c1a
15. Graff L, Frungieri M, Zanner R et al (2002) Expression of histidine decarboxylase and synthesis of histamine by human small cell lung carcinoma. Am J Pathol 160:1561–1565. doi:10.1016/S0002-9440(10)61102-9
16. Haak-Frendscho M, Darvas Z, Hegyesi H et al (2000) Histidine decarboxylase expression in human melanoma. J Invest Dermatol 115:345–352. doi:10.1046/j.1523-1747.2000.00054.x
17. Hori S, Nishiumi S, Kobayashi K et al (2011) A metabolomic approach to lung cancer. Lung Cancer 74:284–292. doi:10.1016/j.lungcan.2011.02.008
18. Kim HJ, Jang SH, Ryu J-S et al (2015) The performance of a novel amino acid multivariate index for detecting lung cancer: A case control study in Korea. Lung Cancer 90:522–527. doi:10.1016/j.lungcan.2015.10.006
19. Kimhofer T, Fye H, Taylor-Robinson S et al (2015) Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review. Br J Cancer 112:1141–1156. doi:10.1038/bjc.2015.38
20. Klupczynska A, Dereziński P, Dyszkiewicz W et al (2016a) Evaluation of serum amino acid profiles’ utility in non-small cell lung cancer detection in Polish population. Lung Cancer 100:71–76. doi:10.1016/j.lungcan.2016.04.008
21. Klupczynska A, Plewa S, Dyszkiewicz W et al (2016b) Determination of low-molecular-weight organic acids in non-small cell lung cancer with a new liquid chromatography–tandem mass spectrometry method. J Pharm Biomed Anal 129:299–309. doi:10.1016/j.jpba.2016.07.028
22. Li Y, Song X, Zhao X et al (2014) Serum metabolic profiling study of lung cancer using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 966:147–153. doi:10.1016/j.jchromb.2014.04.047
23. Maeda J, Higashiyama M, Imaizumi A et al (2010) Possibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control study. BMC Cancer 10:690. doi:10.1186/1471-2407-10-690
24. Masini E, Fabbroni V, Giannini L et al (2005) Histamine and histidine decarboxylase up-regulation in colorectal cancer: correlation with tumor stage. Inflamm Res 54(Suppl 1):S80–S81. doi:10.1007/s00011-004-0437-3
25. Matsuki Y, Tanimoto A, Hamada T, Sasaguri Y (2003) Histidine decarboxylase expression as a new sensitive and specific marker for small cell lung carcinoma. Mod Pathol 16:72–78. doi:10.1097/01.MP.0000044485.14910.3A
26. Mazzone PJ, Wang X-F, Beukemann M et al (2016) Metabolite profiles of the serum of patients with non-small cell carcinoma. J Thorac Oncol 11:72–78. doi:10.1016/j.jtho.2015.09.002
27. Medina MA, Urdiales JL, Rodríguez-Caso C et al (2003) Biogenic amines and polyamines: similar biochemistry for different physiological missions and biomedical applications. Crit Rev Biochem Mol Biol 38:23–59. doi:10.1080/713609209
28. Millington DS, Stevens RD (2011) Acylcarnitines: analysis in plasma and whole blood using tandem mass spectrometry. Methods Mol Biol 708:55–72. doi:10.1007/978-1-61737-985-7_3
29. Miyagi Y, Higashiyama M, Gochi A et al (2011) Plasma free amino acid profiling of five types of cancer patients and its application for early detection. PLoS One 6:e24143. doi:10.1371/journal.pone.0024143
30. Miyamoto S, Taylor S, Barupal D, et al (2015) Systemic metabolomic changes in blood samples of lung cancer patients identified by gas chromatography time-of-flight mass spectrometry. Metabolites 5:192–210. doi:10.3390/metabo5020192
31. Musharraf SG, Mazhar S, Choudhary MI, et al (2015) Plasma metabolite profiling and chemometric analyses of lung cancer along with three controls through gas chromatography-mass spectrometry. Sci Rep 5:8607. doi:10.1038/srep08607
32. Ortega AL, Mena S, Estrela JM (2011) Glutathione in cancer cell death. Cancers (Basel) 3:1285–1310. doi:10.3390/cancers3011285
33. Pluskal T, Castillo S, Villar-Briones A, Oresic M (2010) MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinform11:395. doi:10.1186/1471-2105-11-395
34. Puchades-Carrasco L, Jantus-Lewintre E, Pérez-Rambla C et al (2016) Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer. Oncotarget 7:12904–12916. doi:10.18632/oncotarget.7354
35. Reitzer LJ, Wice BM, Kennell D (1979) Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. J Biol Chem 254:2669–2676. doi:10.1007/s00125-007-0708-y
36. Shingyoji M, Iizasa T, Higashiyama M et al (2013) The significance and robustness of a plasma free amino acid (PFAA) profile-based multiplex function for detecting lung cancer. BMC Cancer 13:77. doi:10.1186/1471-2407-13-77
37. Spratlin JL, Serkova NJ, Eckhardt SG (2009) Clinical applications of metabolomics in oncology: a review. Clin Cancer Res 15:431–440
38. Subramaniam S, Thakur RK, Yadav VK et al (2013) Lung cancer biomarkers: state of the art. J Carcinog 12:3. doi:10.4103/1477-3163.107958
39. Traverso N, Ricciarelli R, Nitti M et al (2013) Role of glutathione in cancer progression and chemoresisstance. Oxid Med Cell Longev 2013:972913. doi:10.1155/2013/972913
40. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–1033. doi:10.1126/science.1160809
41. Wedge DC, Allwood JW, Dunn W et al (2011) Is serum or plasma more appropriate for intersubject comparisons in metabolomic studies? An assessment in patients with small-cell lung cancer. Anal Chem 83:6689–6697. doi:10.1021/ac2012224
42. Wu Q, Wang Y, Gu X et al (2014) Urinary metabolomic study of non-small-cell lung carcinoma based on ultra high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. J Sep Sci 37:1728–1735. doi:10.1002/jssc.201400222
43. Xia J, Sinelnikov IV, Han B, Wishart DS (2015) MetaboAnalyst 3.0–making metabolomics more meaningful. Nucleic Acids Res 43:W251–W257. doi:10.1093/nar/gkv380